Identifying the Barriers of Clinical Trial Access after CAR T-Cell Therapy in Relapsed/Refractory Large B-Cell Lymphoma

被引：0
|
作者：
Kim, Kunhwa [1 ]
Ayers, Amy [2 ]
Ahmed, Sairah [2 ]
Claret, Linda [2 ]
Strati, Paolo [2 ]
Nair, Ranjit [2 ]
Nze, Chijioke [2 ]
Ramdial, Jeremy [3 ]
Torres, Janet [3 ]
Shpall, Elizabeth J. [3 ]
Fayad, Luis E. [4 ]
Nastoupil, Loretta [2 ]
Westin, Jason R. [2 ]
Flowers, Christopher R. [2 ]
Neelapu, Sattva S. [2 ]
Chihara, Dai [2 ]
机构：
[1] Univ Texas MD Anderson, Div Canc Med, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr Houston, Dept Lymphoma & Myeloma, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr Houston, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr Houston, Houston, TX USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-211023
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5121 / 5122
页数：2
相关论文
共 50 条
  • [41] Adaptive bridging radiation therapy for relapsed/refractory B-cell lymphoma patient undergoing CAR T-cell therapy: Case report
    Ababneh, Hazim S.
    Johnson, P. Connor
    Pursley, Jennifer
    Patel, Chirayu G.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 48
  • [42] CAR T-Cell Therapy for Large B-Cell Lymphoma - Who, When, and How?
    Roschewski, Mark
    Longo, Dan L.
    Wilson, Wyndham H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (07): : 692 - 696
  • [43] Relapsed or refractory large B-cell lymphoma after chimeric antigen receptor T-cell therapy: Current challenges and therapeutic options
    Toro-Mijares, Raul Del
    Oluwole, Olalekan
    Jayani, Reena V.
    Kassim, Adetola A.
    Savani, Bipin N.
    Dholaria, Bhagirathbhai
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (01) : 15 - 24
  • [44] Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma
    Zurko, Joanna
    Ramdial, Jeremy
    Shadman, Mazyar
    Ahmed, Sairah
    Szabo, Aniko
    Iovino, Lorenzo
    Tomas, Ana Alarcon
    Sauter, Craig
    Perales, Miguel-Angel
    Shah, Nirav. N.
    Acharya, Utkarsh H.
    Jacobson, Caron
    Soiffer, Robert J.
    Wang, Trent
    Komanduri, Krishna, V
    Jaglowski, Samantha
    Kittai, Adam S.
    Denlinger, Nathan
    Iqbal, Madiha
    Kharfan-Dabaja, Mohamed A.
    Ayala, Ernesto
    Chavez, Julio
    Jain, Michael
    Locke, Frederick L.
    Samara, Yazeed
    Budde, Lihua E.
    Mei, Matthew G.
    Della Pia, Alexandra
    Feldman, Tatyana
    Ahmed, Nausheen
    Jacobs, Ryan
    Ghosh, Nilanjan
    Dholaria, Bhagirathbhai
    Oluwole, Olalekan O.
    Hess, Brian
    Hassan, Ayesha
    Kenkre, Vaishalee P.
    Reagan, Patrick
    Awan, Farrukh
    Nieto, Yago
    Hamadani, Mehdi
    Herrera, Alex F.
    HAEMATOLOGICA, 2023, 108 (01) : 98 - 109
  • [45] Sequential different B-cell antigen-targeted CAR T-cell therapy for pediatric refractory/relapsed Burkitt lymphoma
    Liu, Ying
    Deng, Biping
    Hu, Bo
    Zhang, Wenqun
    Zhu, Qing
    Liu, Yang
    Wang, Shan
    Zhang, Pei
    Yang, Ying
    Yang, Junhan
    Zheng, Qinlong
    Yu, Xinjian
    Gao, Zifen
    Zhou, Chunju
    Han, Wei
    Yang, Jing
    Jin, Ling
    Tong, Chunrong
    Chang, Alex H.
    Zhang, Yonghong
    BLOOD ADVANCES, 2022, 6 (03) : 717 - 730
  • [46] Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies
    Shahid, Sanam
    Prockop, Susan E.
    Flynn, Georgia C.
    Mauguen, Audrey
    White, Charlie O.
    Bieler, Jennifer
    Mcavoy, Devin
    Hosszu, Kinga
    Cancio, Maria I.
    Jakubowski, Ann A.
    Scaradavou, Andromachi
    Boelens, Jaap Jan
    Sauter, Craig S.
    Perales, Miguel-Angel
    Giralt, Sergio A.
    Taylor, Clare
    Chaudhari, Jagrutiben
    Wang, Xiuyan
    Riviere, Isabelle
    Sadelain, Michel
    Brentjens, Renier J.
    Kernan, Nancy A.
    O'Reilly, Richard J.
    Curran, Kevin J.
    BLOOD ADVANCES, 2025, 9 (07) : 1644 - 1657
  • [47] CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma: physician preferences trading off benefits, risks and time to infusion
    Boeri, Marco
    Purdum, Anna G.
    Sutphin, Jessie
    Hauber, Brett
    Kaye, James A.
    FUTURE ONCOLOGY, 2021, 17 (34) : 4697 - 4709
  • [48] Assessment of Time to Insurance Approval and Distance Traveled in Patients Treated with CAR T-Cell Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Thiel, Grace
    Schmit-Pokorny, Kim
    Swanson, Deborah
    Jourdan, Dawn
    Franco, Theresa
    Shostrom, Valerie K.
    Armitage, James O.
    Bierman, Philip J.
    Bociek, R. Gregory
    Kalam, Avyakta
    Vose, Julie M.
    Lunning, Matthew A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S272 - S272
  • [49] Outcomes of Salvage Radiotherapy in Relapsed/Refractory Large B-Cell Lymphoma Patients Following CAR T-Cell Therapy Failure: A Multicenter Pooled Analysis
    Ababneh, Hazim
    Ng, Andrea
    Niemierko, Andrzej
    Frigault, Matthew
    Jacobson, Caron A.
    Patel, Chirayu
    BLOOD, 2024, 144 : 5112 - 5113
  • [50] CD19 CAR T-cell therapy for relapsed/refractory diffuse large B-cell lymphoma (DLBCL) - the Munich Real Life Experience
    Buecklein, V.
    Schmidt, C.
    Blumenberg, V.
    Reischer, A.
    von, Baumgarten L.
    Voelkl, A.
    Wagner, B.
    Humpe, A.
    Reilich, S.
    Bauer, M.
    Ostermann, H.
    Tischer, J.
    Stemmler, H-J.
    von Bergwelt, M.
    Subklewe, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 80 - 81
12345